CHRNA9 Antikörper (N-Term)

Produktnummer ABIN6736367

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch CHRNA9 in WB, IHC und IHC (p). Er zeigt eine Reaktivität gegenüber Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus und Affe.

Kurzübersicht für CHRNA9 Antikörper (N-Term) (ABIN6736367)

Target: CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))

Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Affe

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CHRNA9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-CHRNA9 Antikörper

Bindungsspezifität: N-Term

Marke: IHC-plus™

Spezifität: Human CHRNA9

Homologie: Percent identity by BLAST analysis: Dog, Bovine, Rabbit, Horse, Guinea pig (100%) Mouse (93%) Zebrafish (80%).

Aufreinigung: Immunoaffinity purified

Immunogen: Synthetic peptide from N-Terminus of human CHRNA9 (Q9UGM1, NP_060051). Percent identity by BLAST analysis: Human, Chimpanzee, Gibbon, Monkey, Galago, Marmoset, Elephant, Panda, Dog, Bovine, Bat, Rabbit, Horse, Pig, Opossum, Guinea pig (100%), Mouse (93%), Zebra finch, Chicken, Xenopus, Trachemys (92%), Rat (86%), Turkey, Lizard (85%), Zebrafish (80%).

Type of Immunogen: Synthetic peptide

Anwendungsinformationen

Applikationshinweise: Approved: IHC, IHC-P (5 μg/mL), WB (0.06 μg/mL)

Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in  pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: After adding water, will consist of PBS buffer with 2 % sucrose

Konzentration: Lot specific

Buffer: Lyophilized.

Handhabung: Avoid repeat freeze-thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Details zu CHRNA9

Target: CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))

Andere Bezeichnung: CHRNA9

Hintergrund: Name/Gene ID: CHRNA9
Subfamily: Nicotinic acetylcholine receptor
Family: Ion Channel

Synonyms: CHRNA9, AChR-alpha9, NACHR alpha 9, NACHRA9, HSA243342, NACHR alpha-9

Gen-ID: 55584

NCBI Accession: NP_060051

UniProt: Q9UGM1

Pathways: Sensory Perception of Sound